Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $146.0200 (-0.92%) ($144.3200 - $147.8900) on Wed. Jun. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.6% (three month average) | RSI | 39 | Latest Price | $146.0200(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(39%) SPLV(29%) DIA(28%) XLP(27%) IBB(26%) | Factors Impacting ABBV price | ABBV will decline at least -0.8% in a week (0% probabilities). VIXM(-18%) UUP(-14%) TBT(-7%) UNG(-1%) VXX(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.8% (StdDev 1.6%) | Hourly BBV | -0.4 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $151.3 | 5 Day Moving Average | $149.18(-2.12%) | 10 Day Moving Average | $149.73(-2.48%) | 20 Day Moving Average | $151.3(-3.49%) | To recent high | -16.5% | To recent low | 0% | Market Cap | $257.621b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |